SunTrust Robinson Humphrey Maintains Medtronic PLC to Buy with Price Target $98.00

Brokerage firm SunTrust Robinson Humphrey Maintains its rating on Medtronic PLC(NYSE:MDT). In a research note issued to the investors, the brokerage major Raises the price-target to $98.00 per share. The shares have been rated Buy. The rating by SunTrust Robinson Humphrey was issued on Jun 13, 2016.

In a different note, Guggenheim Securities said it Initiates Coverage on Medtronic PLC, according to a research note issued on Jun 9, 2016. The shares have been rated ‘Neutral’ by the firm. On Jun 2, 2016, Deutsche Bank said it Maintains its rating on Medtronic PLC. In the research note, the firm Raises the price-target to $90.00 per share. The shares have been rated ‘Buy’ by the firm. On Jun 1, 2016, BTIG Research said it Downgrades its rating on Medtronic PLC. In the research note, the firm Removes the price-target to $82.00 per share. The shares have been rated ‘Neutral’ by the firm. SunTrust Robinson Humphrey said it Initiates Coverage on Medtronic PLC, according to a research note issued on Apr 25, 2016. The shares have been rated ‘Buy’ by the firm. Nomura said it Initiates Coverage on Medtronic PLC, according to a research note issued on Mar 17, 2016. The shares have been rated ‘Buy’ by the firm.

Medtronic PLC (MDT) shares turned negative on Fridays trading session with the shares closing down -0.45 points or -0.53% at a volume of 55,18,212. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $84.6. The peak price level was also seen at $84.6 while the days lowest was $83.455. Finally the shares closed at $84.14. The 52-week high of the shares is $86.31 while the 52-week low is $55.54. According to the latest information available, the market cap of the company is $151,540 M.

Medtronic PLC(MDT) last announced its earnings results on May 31, 2016 for Fiscal Year 2016 and Q4.Company reported revenue of $7.57B. Analysts had an estimated revenue of $7.48B. Earnings per share were $1.27. Analysts had estimated an EPS of $1.27.

Several Insider Transactions has been reported to the SEC. On Jun 7, 2016, Richard Kuntz (SrVP & Chief Scien, Clin, Reg) sold 49,905 shares at $82.60 per share price.Also, On Jun 3, 2016, Hoedt Rob Ten (EVP & President EMEAC) sold 12,100 shares at $80.54 per share price.On Mar 22, 2016, Shirley A Jackson (director) sold 1,238 shares at $75.60 per share price, according to the Form-4 filing with the securities and exchange commission.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops manufactures and markets its medical devices and technologies to hospitals physicians clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group Minimally Invasive Technologies Group Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine Neuromodulation Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic Inc. is a subsidiary of the Company.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *